bio_image
HIGHLIGHTS
We are now AAALAC accredited
07 / Oct / 2026 Versa Biomedical
On 30 September 2026, Versa Biomedical achieved AAALAC International accreditation, the global benchmark for the humane care and use of…
Read more
bio_image
Regulation, Know How, Continuity, Accessibility: Why Location Decides a Study’s Future
22 / Sep / 2026 Versa Biomedical
When a preclinical study is being planned, there is a decision that is rarely given the weight it deserves: where…
Read more
bio_image
Swine in Ophthalmology Research: Closing the Translational Gap Between Bench and Clinic
08 / Sep / 2026 Versa Biomedical
Ocular drug and device development carries a translation problem of its own. Rodent eyes are simply too small, too fast-healing,…
Read more
bio_image
We are hiring a Sales technician
07 / Sep / 2026 Versa Biomedical
The role As Sales Technician, you will drive our commercial growth across the Medical Devices, Tissue Regeneration, New Materials and…
Read more
bio_image
We are hiring a QA technician
27 / Aug / 2026 Versa Biomedical
The role The QA Technician supports quality assurance across the organisation, managing documentation, monitoring compliance and contributing to continuous improvement…
Read more
bio_image
Oncology leads the preclinical market. Versa Biomedical has bred the first transgenic miniature pig in Europe with tumours on demand.
21 / Jul / 2026 Versa Biomedical
According to Grand View Research, oncology was the largest segment within the preclinical CRO industry in 2025. Behind that leadership…
Read more
bio_image
Sepsis in the Porcine Model: Why Physiological Relevance Makes the Difference in Clinical Translation
10 / Jul / 2026 Versa Biomedical
Sepsis research has a translation problem: despite decades of preclinical work, no new therapy has clearly improved patient outcomes, and…
Read more